Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and …
Over the last 12 months, insiders at Simulations Plus, Inc. have bought $0 and sold $11.86M worth of Simulations Plus, Inc. stock.
On average, over the past 5 years, insiders at Simulations Plus, Inc. have bought $1.4M and sold $12.16M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 24,000 shares for transaction amount of $1.4M was made by WOLTOSZ WALTER S () on 2020‑08‑26.
2024-11-01 | Sale | 20,000 0.0995% | $27.66 | $553,200 | -1.04% | |||
2024-10-01 | Sale | 20,000 0.1006% | $31.26 | $625,200 | -3.14% | |||
2024-09-27 | Sale | director | 750 0.0038% | $31.54 | $23,655 | -3.80% | ||
2024-09-03 | Sale | 20,000 0.1014% | $35.18 | $703,677 | -9.14% | |||
2024-09-03 | Sale | director | 650 0.0034% | $35.95 | $23,368 | -9.14% | ||
2024-08-01 | Sale | 20,000 0.0991% | $39.63 | $792,547 | -18.73% | |||
2024-07-01 | Sale | 20,000 0.098% | $46.71 | $934,227 | 0.00% | |||
2024-06-28 | Sale | director | 750 0.0039% | $49.32 | $36,990 | 0.00% | ||
2024-06-03 | Sale | 20,000 0.1006% | $46.25 | $924,978 | -20.94% | |||
2024-06-03 | Sale | director | 650 0.0034% | $48.26 | $31,369 | -20.94% | ||
2024-05-14 | Sale | director | 3,000 0.0152% | $50.13 | $150,390 | -25.50% | ||
2024-05-14 | Sale | director | 500 0.0025% | $50.00 | $25,000 | -25.50% | ||
2024-05-07 | Sale | director | 3,250 0.0163% | $48.31 | $157,008 | -23.88% | ||
2024-05-07 | Sale | director | 650 0.0033% | $48.30 | $31,395 | -23.88% | ||
2024-05-01 | Sale | 20,000 0.0993% | $45.95 | $918,984 | -19.70% | |||
2024-04-01 | Sale | 20,000 0.1004% | $39.94 | $798,867 | +2.28% | |||
2024-03-01 | Sale | 20,000 0.1% | $41.41 | $828,240 | +3.11% | |||
2024-02-02 | Sale | 1,055 0.005% | $37.64 | $39,710 | +10.43% | |||
2024-02-01 | Sale | 18,945 0.0915% | $38.02 | $720,237 | +9.80% | |||
2024-01-04 | Sale | director | 1,000 0.0053% | $43.74 | $43,740 | +0.45% |
WOLTOSZ WALTER S | 3462584 17.2549% | $30.97 | 2 | 87 | +107.53% | |
WOLTOSZ VIRGINIA E | 4097907 20.4209% | $30.97 | 1 | 26 | +210.67% | |
D ARGENIO DAVID Z | 33608 0.1675% | $30.97 | 6 | 8 | +17.51% |
BlackRock | $103.43M | 12.56 | 2.51M | -1.15% | -$1.2M | <0.01 | |
Conestoga Capital Advisors, LLC | $93.15M | 11.31 | 2.26M | +0.2% | +$188,425.88 | 1.37 | |
Neuberger Berman | $53.52M | 6.5 | 1.3M | -1.51% | -$822,794.25 | 0.04 | |
The Vanguard Group | $46.71M | 5.67 | 1.14M | +1.13% | +$519,971.40 | <0.01 | |
Ranger Investment Management L P | $34.35M | 4.17 | 834,828 | -10.34% | -$3.96M | 2.25 |